Gabapentoids is the collective term for Pregabalin and Gabapentin.  The use of these drugs has steadily increased in England. There were 8.2 million prescriptions in 2013, which had risen to 12.1 million by 2016. 

In April 2019, Pregabalin and Gabapentin were reclassified as Schedule 3 controlled drugs to reduce the growing number of deaths associated with their misuse.  This followed a Government consultation and recommendations from the Advisory Council on the Misuse of Drugs for additional safeguards to be put in place because of concerns around the misuse of these drugs. 

To put this into context, deaths associated with Pregabalin rose from 4 in 2012 to 111 in 2016. Similarly, deaths related to Gabapentin rose from 8 in 2012 to 59 deaths in 2016. Most of the deaths were related to a Gabapentoid being taken with an opiate drug (codeine, tramadol, morphine or morphine-like medication). 

Patient safety is at the heart of our prescribing at The Lawson Practice. Due to the overwhelming evidence of harm associated with gabapentin and opiates, we are taking major steps to reduce this risk. 

We will be doing the following: 

If you have any concerns about any of the above don't hesitate to get in touch with your GP to discuss further